(LYB) LyondellBasell Industries - Ratings and Ratios
Olefins, Polyolefins, Polyethylene, Polypropylene, PropyleneOxide
LYB EPS (Earnings per Share)
LYB Revenue
Description: LYB LyondellBasell Industries
LyondellBasell Industries N.V. is a global chemical company operating across multiple segments, including Olefins and Polyolefins, Intermediates and Derivatives, Advanced Polymer Solutions, Refining, and Technology. The companys diverse product portfolio includes olefins, polyolefins, propylene oxide, and derivatives, as well as refined products like gasoline and distillates. Its products serve various applications, such as food packaging, automotive components, and paints and coatings.
From a financial perspective, LyondellBasell has a market capitalization of approximately $19.93 billion USD, with a forward P/E ratio of 16.10, indicating a relatively stable valuation. The companys Return on Equity (RoE) stands at 8.23%, suggesting a decent level of profitability. To further evaluate the companys performance, we can examine additional KPIs such as Debt-to-Equity ratio, EBITDA margin, and dividend yield. A Debt-to-Equity ratio of around 0.83 (based on industry averages) and an EBITDA margin of approximately 15-20% (depending on the industry cycle) could be considered reasonable for a company in the commodity chemicals sector. A dividend yield of around 4-5% could be attractive to income-seeking investors.
To gain a deeper understanding of LyondellBasells prospects, its essential to analyze the companys operational efficiency, cost structure, and exposure to commodity price fluctuations. The companys ability to maintain a competitive edge in the global market, invest in research and development, and adapt to changing regulatory environments will be crucial in driving long-term growth. Key performance indicators such as production capacity utilization, raw material costs, and research and development expenses as a percentage of sales could provide valuable insights into the companys operational performance.
LYB Stock Overview
| Market Cap in USD | 16,169m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception | 2010-04-28 |
LYB Stock Ratings
| Growth Rating | -27.5% |
| Fundamental | 35.2% |
| Dividend Rating | 84.4% |
| Return 12m vs S&P 500 | -46.1% |
| Analyst Rating | 3.27 of 5 |
LYB Dividends
| Dividend Yield 12m | 8.60% |
| Yield on Cost 5y | 11.00% |
| Annual Growth 5y | 4.64% |
| Payout Consistency | 94.4% |
| Payout Ratio | 1.5% |
LYB Growth Ratios
| Growth Correlation 3m | -21.6% |
| Growth Correlation 12m | -90% |
| Growth Correlation 5y | 19.7% |
| CAGR 5y | 2.83% |
| CAGR/Max DD 5y | 0.06 |
| Sharpe Ratio 12m | -1.59 |
| Alpha | -49.80 |
| Beta | 0.746 |
| Volatility | 56.90% |
| Current Volume | 3206.3k |
| Average Volume 20d | 5084.5k |
| Stop Loss | 53.8 (-4.9%) |
| Signal | 0.35 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (259.0m TTM) > 0 and > 6% of Revenue (6% = 2.11b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -5.59pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 13.75% (prev 17.16%; Δ -3.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 1.78b > Net Income 259.0m (YES >=105%, WARN >=100%) |
| Net Debt (10.12b) to EBITDA (2.04b) ratio: 4.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (322.0m) change vs 12m ago -1.23% (target <= -2.0% for YES) |
| Gross Margin 9.50% (prev 12.56%; Δ -3.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 97.09% (prev 106.3%; Δ -9.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.23 (EBITDA TTM 2.04b / Interest Expense TTM 504.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.21
| (A) 0.14 = (Total Current Assets 11.08b - Total Current Liabilities 6.24b) / Total Assets 35.35b |
| (B) 0.25 = Retained Earnings (Balance) 8.73b / Total Assets 35.35b |
| (C) 0.02 = EBIT TTM 620.0m / Avg Total Assets 36.21b |
| (D) 0.38 = Book Value of Equity 8.75b / Total Liabilities 23.32b |
| Total Rating: 2.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.17
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 1.79% = 0.90 |
| 3. FCF Margin 1.32% = 0.33 |
| 4. Debt/Equity 0.95 = 2.07 |
| 5. Debt/Ebitda 5.54 = -2.50 |
| 6. ROIC - WACC -3.45% = -4.32 |
| 7. RoE 2.06% = 0.17 |
| 8. Rev. Trend -75.55% = -3.78 |
| 9. Rev. CAGR -15.70% = -2.50 |
| 10. EPS Trend -47.91% = -1.20 |
| 11. EPS CAGR -44.35% = -2.50 |
What is the price of LYB shares?
Over the past week, the price has changed by +7.68%, over one month by -7.84%, over three months by +2.45% and over the past year by -37.24%.
Is LyondellBasell Industries a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYB is around 54.05 USD . This means that LYB is currently overvalued and has a potential downside of -4.51%.
Is LYB a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 13
- Sell: 1
- Strong Sell: 2
What are the forecasts/targets for the LYB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.8 | 9.2% |
| Analysts Target Price | 69.4 | 22.6% |
| ValueRay Target Price | 58.7 | 3.8% |
Last update: 2025-08-14 02:54
LYB Fundamental Data Overview
CCE Cash And Equivalents = 1.70b USD (last quarter)
P/E Trailing = 106.9575
P/E Forward = 15.015
P/S = 0.4183
P/B = 1.3577
P/EG = 0.9872
Beta = 0.867
Revenue TTM = 35.15b USD
EBIT TTM = 620.0m USD
EBITDA TTM = 2.04b USD
Long Term Debt = 11.21b USD (from longTermDebt, last quarter)
Short Term Debt = 119.0m USD (from shortTermDebt, last quarter)
Debt = 11.33b USD (Calculated: Short Term 119.0m + Long Term 11.21b)
Net Debt = 10.12b USD (from netDebt column, last quarter)
Enterprise Value = 25.80b USD (16.17b + Debt 11.33b - CCE 1.70b)
Interest Coverage Ratio = 1.23 (Ebit TTM 620.0m / Interest Expense TTM 504.0m)
FCF Yield = 1.79% (FCF TTM 463.0m / Enterprise Value 25.80b)
FCF Margin = 1.32% (FCF TTM 463.0m / Revenue TTM 35.15b)
Net Margin = 0.74% (Net Income TTM 259.0m / Revenue TTM 35.15b)
Gross Margin = 9.50% ((Revenue TTM 35.15b - Cost of Revenue TTM 31.81b) / Revenue TTM)
Tobins Q-Ratio = 2.95 (Enterprise Value 25.80b / Book Value Of Equity 8.75b)
Interest Expense / Debt = 1.44% (Interest Expense 163.0m / Debt 11.33b)
Taxrate = 14.97% (from yearly Income Tax Expense: 240.0m / 1.60b)
NOPAT = 527.2m (EBIT 620.0m * (1 - 14.97%))
Current Ratio = 1.77 (Total Current Assets 11.08b / Total Current Liabilities 6.24b)
Debt / Equity = 0.95 (Debt 11.33b / last Quarter total Stockholder Equity 11.91b)
Debt / EBITDA = 5.54 (Net Debt 10.12b / EBITDA 2.04b)
Debt / FCF = 24.47 (Debt 11.33b / FCF TTM 463.0m)
Total Stockholder Equity = 12.57b (last 4 quarters mean)
RoA = 0.73% (Net Income 259.0m, Total Assets 35.35b )
RoE = 2.06% (Net Income TTM 259.0m / Total Stockholder Equity 12.57b)
RoCE = 2.61% (Ebit 620.0m / (Equity 12.57b + L.T.Debt 11.21b))
RoIC = 2.20% (NOPAT 527.2m / Invested Capital 23.94b)
WACC = 5.65% (E(16.17b)/V(27.50b) * Re(8.76%)) + (D(11.33b)/V(27.50b) * Rd(1.44%) * (1-Tc(0.15)))
Shares Correlation 5-Years: -97.50 | Cagr: -0.91%
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.62% ; FCFE base≈1.30b ; Y1≈866.6m ; Y5≈407.6m
Fair Price DCF = 22.02 (DCF Value 7.08b / Shares Outstanding 321.6m; 5y FCF grow -38.98% → 3.0% )
Revenue Correlation: -75.55 | Revenue CAGR: -15.70%
Rev Growth-of-Growth: -4.99
EPS Correlation: -47.91 | EPS CAGR: -44.35%
EPS Growth-of-Growth: -99.02
Additional Sources for LYB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle